Exclusive: Takeda launches Actos DTC campaign today
Takeda is kicking off a direct-to-consumer campaign for type 2 diabetes pill Actos today, as the FDA considers whether Actos' direct rival, the GlaxoSmithKline drug Avandia, can remain on the market.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.